Related Articles
Clinical usefulness of testing for UDP glucuronosyltransferase 1 family, polypeptide A1 polymorphism prior to the inititation of irinotecan-based chemotherapy
Gene expression profiles of colorectal carcinoma in response to neo-adjuvant chemotherapy
Distribution of uridine diphosphate glucuronosyltransferase 1A polymorphisms and their role in irinotecan‑induced toxicity in patients with cancer
Prevalence of topoisomerase I genetic mutations and UGT1A1 polymorphisms associated with irinotecan in individuals of Asian descent
A novel system for predicting the toxicity of irinotecan based on statistical pattern recognition with UGT1A genotypes